News Summary
Valencia Technologies, based in California, has announced a $35 million strategic investment from Brooks Advisory Group to advance the commercialization of its eCoin system. Recently appointed CEO James D. Surek will lead the company in bringing this FDA-approved device for urgency urinary incontinence to broader markets. The eCoin is a small neurostimulator aimed at reducing incontinence episodes, marking a significant advancement in minimally invasive UUI treatments. The collaboration also includes consulting services to enhance market entry strategies and overall sales efforts.
California – Valencia Technologies, a privately funded medical device company based in Valencia, California, has announced the acquisition of a strategic investment of up to $35 million to bolster its efforts in commercialization of its key product, the eCoin system, which is aimed at treating urgency urinary incontinence (UUI). This significant financial backing comes from the Brooks Advisory Group, a member of Brooks Management Group (BMG).
The company has also appointed James D. Surek as the new CEO. Surek has extensive experience in the medical device industry, having successfully driven revenue growth and operational efficiency in previous roles. His leadership is expected to guide Valencia Technologies through its next growth phase, particularly in bringing the eCoin system to broader markets.
The primary goal of the investment is to accelerate the commercialization of the eCoin system, which has already received FDA approval. The eCoin device is a small neurostimulator, about the size of a coin, implanted under the skin near the ankle in a minimally invasive outpatient procedure. This device delivers periodic stimulation to the tibial nerve twice a week, resulting in a substantial reduction of urge urinary incontinence episodes by at least 50% in 75% of patients after one year of use.
Approval for the eCoin system was granted by the FDA in 2022, marking it as the first and only FDA-approved subcutaneous implantable tibial nerve stimulator specifically for UUI. This milestone positions Valencia Technologies uniquely within the growing field of minimally invasive UUI treatments.
In addition to the investment, Brooks Advisory Group will provide consulting services that include strategies for commercialization, sales assistance, reimbursement solutions, and financial advisory services. This collaborative support is anticipated to strengthen Valencia Technologies’ market entry and overall sales efforts.
The management team will feature experienced executives, including Dain Black and Ryan Brooks, alongside Surek, as well as existing board members Jeff Greiner and Don Hubbard. With their combined expertise, Valencia is poised to effectively navigate its commercialization challenges.
Surek’s experience in the medical device sector is substantial. He previously contributed to a rapid revenue increase of over $200 million within three years at Advanced Bionics, a company eventually acquired by Boston Scientific for approximately $3 billion. He has also been instrumental in turning around Entellus Medical, where he increased revenue from less than $1 million to over $70 million, which led to a successful IPO within four years.
Alongside the company’s innovative technology, healthcare professionals are beginning to recognize the eCoin system as an alternative to traditional medication and more invasive surgical procedures. The device offers a streamlined experience post-implantation, which involves minimal follow-up programming sessions and eliminates the need for weekly recharging of the device, further enhancing patient convenience.
Valencia Technologies stands at the threshold of a significant advancement in treatments for UUI, backed by promising financial support and a capable leadership team, aiming to elevate the standard of care for those suffering from overactive bladder symptoms. The combination of these resources and innovative technology could enable Valencia Technologies to make lasting impacts in the realm of patient care in the field of urology.
Deeper Dive: News & Info About This Topic
- PR Newswire: Valencia Technologies Announces Strategic Investment
- Wikipedia: Urinary Incontinence
- Los Angeles Business Journal: Avita Gets FDA Nod for Device
- Google Search: UUI Treatment
- Fortune: AI Integration in Healthcare
- Encyclopedia Britannica: Medical Device
- Crain’s Chicago Business: Who’s Who in Chicago Business
- Google Scholar: Medical Device Commercialization
Author: STAFF HERE SAN DIEGO WRITER
SAN DIEGO STAFF WRITER The SAN DIEGO STAFF WRITER represents the experienced team at HERESanDiego.com, your go-to source for actionable local news and information in San Diego, San Diego County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Comic-Con International, San Diego County Fair, and San Diego Pride Festival. Our coverage extends to key organizations like the San Diego Regional Chamber of Commerce and United Way of San Diego County, plus leading businesses in biotechnology, healthcare, and technology that power the local economy such as Qualcomm, Illumina, and Scripps Health. As part of the broader HERE network, including HEREAnaheim.com, HEREBeverlyHills.com, HERECostaMesa.com, HERECoronado.com, HEREHollywood.com, HEREHuntingtonBeach.com, HERELongBeach.com, HERELosAngeles.com, HEREMissionViejo.com, and HERESantaAna.com, we provide comprehensive, credible insights into California's dynamic landscape.
